Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. The search for better prognostic models in myelodysplastic syndromes.

    ... for discerning the best therapy, which can vary from supportive care to allogeneic stem cell transplantation. The most widely used ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes.

    ... of treatment includes cytoxic chemotherapy and supportive care . Over the last decade, promising results from studies focusing on ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Standard therapy for patients with myelodysplastic syndromes

    ... leukemia. Treatment for patients with MDS ranges from supportive care with blood products and/or growth factors up to allogeneic stem cell ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Azacytidine for the treatment of myelodysplastic syndromes in the elderly.

    ... MDS treated with 5-AZA as well as the management and supportive care measures for adverse events. As expected, based on available clinical ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Infections in patients with aplastic anemia.

    ... from neutropenia is directly related to survival, and supportive care plays a large role in protection while the patient is in a ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Management of aplastic anemia: the role of systematic reviews and meta-analyses.

    ... roles of alloHCT, IST, hematopoietic growth factors and supportive care . Bone Marrow ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.

    ... effective novel conditioning regimens, improvement of supportive care and expansion of the donor registry. Decision making regarding the ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes.

    ... when analysis was restricted to 602 patients managed by supportive care . MK adversely affected survival in both poor and very poor karyotype ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents.

    ... patients with MDS for whom HMAs have failed, including supportive care alone, cytotoxic therapy, lenalidomide , histone deacetylase ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. Treatment of myelodysplastic syndromes in elderly patients.

    ... the longest possible time. To achieve these objectives, supportive care is essential. Likewise, immunomodulatory drugs, such as ...

    Research Article last updated 07/20/2018 - 5:14pm.